Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Hirasawa

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 24, 2004
[Efficacy of selective digestive decontamination (SDD) for severe acute pancreatitis]Nobuya Kitamura, Takeshi Hirano, Takeshi Moriguchi, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 24, 2004
[Indications for and clinical efficacy of continuous hemodiafiltration (CHDF) for severe acute pancreatitis]Hiroyuki Hirasawa, Shigeto Oda, Hidetoshi Shiga, et al.
Critical Care Medicine|October 1, 2009
Association between lymphotoxin-alpha (tumor necrosis factor-beta) intron polymorphism and predisposition to severe sepsis is modified by gender and ageEizo Watanabe, Timothy G Buchman, Hiroyuki Hirasawa, et al.
Cardiovascular Toxicology|July 18, 2006
Nicotine enhances human vascular endothelial cell expression of ICAM-1 and VCAM-1 via protein kinase C, p38 mitogen-activated protein kinase, NF-kappaB, and AP-1Hirokazu Ueno, Sanjeev Pradhan, David Schlessel, et al.
Nihon Geka Gakkai Zasshi|February 26, 2003
[Endotoxin removal in septic shock]Kenichi Matsuda, Hiroyuki Hirasawa, Shigeto Oda, et al.
Blood Purification|October 26, 2012
Continuous hemodiafiltration with a cytokine-adsorbing hemofilter for sepsisHiroyuki Hirasawa, Shigeto Oda, Masataka Nakamura, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 10, 2002
Use of antifungal agents in febrile patients nonresponsive to antibacterial treatment: the current status in surgical and critical care patients in JapanNaoki Aikawa, Yoshinobu Sumiyama, Shinya Kusachi, et al.
The Japanese Journal of Antibiotics|June 10, 2008
[Influence of the diagnosis and treatment guidelines for mycosis profunda (deep mycosis) in the field of emergency and critical care medicine--with reference to patient background]Hideki Ishikawa, Shigeto Oda, Atsuo Murata, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 10, 2006
Blood purification for hypercytokinemiaTaka-aki Nakada, Hiroyuki Hirasawa, Shigeto Oda, et al.
Critical Care Medicine|January 13, 2005
Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor- and interleukin-1-related gene polymorphismsEizo Watanabe, Hiroyuki Hirasawa, Shigeto Oda, et al.
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 24, 2004
[Efficacy of selective digestive decontamination (SDD) for severe acute pancreatitis]Nobuya Kitamura, Takeshi Hirano, Takeshi Moriguchi, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 24, 2004
[Indications for and clinical efficacy of continuous hemodiafiltration (CHDF) for severe acute pancreatitis]Hiroyuki Hirasawa, Shigeto Oda, Hidetoshi Shiga, et al.
Critical Care Medicine|October 1, 2009
Association between lymphotoxin-alpha (tumor necrosis factor-beta) intron polymorphism and predisposition to severe sepsis is modified by gender and ageEizo Watanabe, Timothy G Buchman, Hiroyuki Hirasawa, et al.
Cardiovascular Toxicology|July 18, 2006
Nicotine enhances human vascular endothelial cell expression of ICAM-1 and VCAM-1 via protein kinase C, p38 mitogen-activated protein kinase, NF-kappaB, and AP-1Hirokazu Ueno, Sanjeev Pradhan, David Schlessel, et al.
Nihon Geka Gakkai Zasshi|February 26, 2003
[Endotoxin removal in septic shock]Kenichi Matsuda, Hiroyuki Hirasawa, Shigeto Oda, et al.
Blood Purification|October 26, 2012
Continuous hemodiafiltration with a cytokine-adsorbing hemofilter for sepsisHiroyuki Hirasawa, Shigeto Oda, Masataka Nakamura, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 10, 2002
Use of antifungal agents in febrile patients nonresponsive to antibacterial treatment: the current status in surgical and critical care patients in JapanNaoki Aikawa, Yoshinobu Sumiyama, Shinya Kusachi, et al.
The Japanese Journal of Antibiotics|June 10, 2008
[Influence of the diagnosis and treatment guidelines for mycosis profunda (deep mycosis) in the field of emergency and critical care medicine--with reference to patient background]Hideki Ishikawa, Shigeto Oda, Atsuo Murata, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 10, 2006
Blood purification for hypercytokinemiaTaka-aki Nakada, Hiroyuki Hirasawa, Shigeto Oda, et al.
Critical Care Medicine|January 13, 2005
Extremely high interleukin-6 blood levels and outcome in the critically ill are associated with tumor necrosis factor- and interleukin-1-related gene polymorphismsEizo Watanabe, Hiroyuki Hirasawa, Shigeto Oda, et al.
Pageof 9